Featured

24 January 2024

ACCORD: new guideline to support consistent and complete reporting of consensus methods in biomedical research

Oxford PharmaGenesis has contributed to the development of the new ACCORD reporting guideline to help the medical and scientific communities to improve the reporting of research involving consensus methodologies. The guideline was published in the non-profit open access journal PLOS Medicine.

All
  • All
  • News
  • Articles
  • Events

Oxford PharmaGenesis delivers global webinar on best practice in the publication and communication of Real World Evidence

Nearly 200 medical communications and pharma industry professionals worldwide tuned in yesterday to hear Oxford PharmaGenesis deliver a webinar on publication and communication of Real World Evidence (RWE). Commercial Director Richard White and Account Director Tim Koder presented the webinar as part the International Society of Medical Publications Professionals (ISMPP) online educational series, ISMPP University…

Continue reading

Oxford PharmaGenesis goes to Buckingham Palace

Managing Director Chris Winchester and Commercial Director Richard White are proud to have represented Oxford PharmaGenesis as a winner of the Queen’s Awards for Enterprise 2015 at a reception at Buckingham Palace last night. The reception, hosted by the Queen and the Duke of Edinburgh, was attended by the Duke of York, Princess Eugenie of…

Continue reading

Oxford PharmaGenesis shows its support for Anthony Nolan

Anthony Nolan, a charity dedicated to saving the lives of patients needing a stem cell transplant, visited us in our Oxford office today. Irina Evseeva, Head of Specialist Services, gave a presentation to employees showing the science behind patient and donor matching, and Karen Archer, Regional Register Development Manager was on-site to accept registrations and…

Continue reading

Lord-Lieutenant leads lively celebrations

Oxford PharmaGenesis was today presented with the Queen’s Award for Enterprise by the Lord-Lieutenant of Oxfordshire, Tim Stevenson OBE. The award was made in recognition of the company’s outstanding growth in overseas sales, which has more than doubled over the past 4 years, from £4.0 million in 2010 to £8.9 million in 2013.

Continue reading

Oxford PharmaGenesis flies the flag for HealthScience at the Houses of Parliament

Oxford PharmaGenesis was proud to represent HealthScience communication at the Institute of Directors (IoD) Summer Reception, held in the delightful setting of the Terrace Pavilion at the House of Commons in London on Monday 29 June. Commercial Director Dr Richard White was one of a select group of IoD members from around the country, who…

Continue reading

Oxford PharmaGenesis featured in Director magazine

This month’s issue of Director magazine – the official publication of the UK Institute of Directors (IoD) – includes an interview with Dr Richard White, Commercial Director at Oxford PharmaGenesis. In the feature article, which profiles the IoD’s business information and advisory services, Richard describes how Oxford PharmaGenesis has used these services to address specific…

Continue reading